66 related articles for article (PubMed ID: 7084079)
1. [Raised plasma glucagon levels in obesity (author's transl)].
Starke A; Starke G; Jörgens V; Berger M; Zimmermann H
Dtsch Med Wochenschr; 1982 Jul; 107(29-30):1125-8. PubMed ID: 7084079
[TBL] [Abstract][Full Text] [Related]
2. Pattern of obesity and insulin, glucagon, sex hormone binding globulin and lipids in obese Arab women.
Emara MK; Saadah A; Hassan M; Moussa M; Hourani H
Diabetes Res; 1989 Apr; 10(4):175-81. PubMed ID: 2692944
[TBL] [Abstract][Full Text] [Related]
3. Studies of glucose intolerance in cirrhosis of the liver.
Shankar TP; Solomon SS; Duckworth WC; Himmelstein S; Gray S; Jerkins T; Bobal MA; Iyer RS
J Lab Clin Med; 1983 Oct; 102(4):459-69. PubMed ID: 6352838
[TBL] [Abstract][Full Text] [Related]
4. Fasting and postprandial plasma glucagon and glucagon-like immunoreactivity are normal in obese Pima Indians.
Vasquez B; Nagulesparan M; Unger RH
Horm Metab Res; 1983 May; 15(5):218-20. PubMed ID: 6347855
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic polypeptide response to secretin in obesity: effects of glucose intolerance.
Glaser B; Zoghlin G; Pienta K; Vinik AI
Horm Metab Res; 1988 May; 20(5):288-92. PubMed ID: 3042579
[TBL] [Abstract][Full Text] [Related]
6. Decreased basal levels of glucagon-like peptide-1 after weight loss in obese subjects.
de Luis DA; Gonzalez Sagrado M; Conde R; Aller R; Izaola O
Ann Nutr Metab; 2007; 51(2):134-8. PubMed ID: 17536190
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of hyperinsulinemia and hyperglucagonemia after liver transplantation.
Sika M; Blair KT; Jabbour K; Williams PE; Donovan KL; Drougas JG; Becker YT; Bradley AL; Van Buren DH; Flakoll PJ; Chapman WC; Wright JK; Pinson CW
J Surg Res; 1997 Jul; 70(2):144-50. PubMed ID: 9245563
[TBL] [Abstract][Full Text] [Related]
8. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects.
Valverde I; Puente J; Martín-Duce A; Molina L; Lozano O; Sancho V; Malaisse WJ; Villanueva-Peñacarrillo ML
Obes Surg; 2005 Mar; 15(3):387-97. PubMed ID: 15826475
[TBL] [Abstract][Full Text] [Related]
9. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids.
Fagerberg B; Berglund A; Andersson OK; Berglund G
J Hypertens; 1992 Sep; 10(9):1053-61. PubMed ID: 1328365
[TBL] [Abstract][Full Text] [Related]
10. [Plasma insulin changes in obesity with or without abnormal glucose tolerance].
García Pascual IJ; González Ruiz JM
An Med Interna; 1993 Oct; 10(10):473-8. PubMed ID: 8136423
[TBL] [Abstract][Full Text] [Related]
11. Glucose resistance contributes to diabetes mellitus in cirrhosis.
Petrides AS; Schulze-Berge D; Vogt C; Matthews DE; Strohmeyer G
Hepatology; 1993 Aug; 18(2):284-91. PubMed ID: 8340056
[TBL] [Abstract][Full Text] [Related]
12. Effect of glucagon infusion on blood glucose, plasma immunoreactive insulin, growth hormone and adenosine 3'5'-monophosphate in obese children.
Molnár D; Kardos M; Soltész G
Acta Paediatr Acad Sci Hung; 1981; 22(4):325-9. PubMed ID: 6282041
[TBL] [Abstract][Full Text] [Related]
13. Effect of protein-supplemented fasting on metabolic and hormonal responses to epinephrine infusion in obese subjects.
Scheen A; Cession-Fossion A; Scheen-Lavigne M; Luyckx A
Horm Metab Res; 1982 May; 14(5):240-5. PubMed ID: 7047346
[TBL] [Abstract][Full Text] [Related]
14. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
15. [Weight reduction and glucose intolerance in obese subjects (author's transl)].
Berger M; Baumhoff E; Gries FA
Dtsch Med Wochenschr; 1976 Feb; 101(9):307-11. PubMed ID: 1248416
[TBL] [Abstract][Full Text] [Related]
16. Influence of obesity on basal glucagon levels in non-diabetic and diabetic Nauruans.
Alford FP; Zimmet P; Chisholm DJ; Whitehouse S
Clin Endocrinol (Oxf); 1983 Dec; 19(6):721-5. PubMed ID: 6360432
[TBL] [Abstract][Full Text] [Related]
17. Hyperinsulinaemia in non-obese subjects with hypertriglyceridaemia: a preliminary report.
Sum CF; Wang KW; Tan CE; Fok AC; Chew LS; Tan YT
Ann Acad Med Singap; 1992 Jan; 21(1):10-3. PubMed ID: 1590641
[TBL] [Abstract][Full Text] [Related]
18. Elevated pancreatic glucagon in obesity.
Starke AA; Erhardt G; Berger M; Zimmermann H
Diabetes; 1984 Mar; 33(3):277-80. PubMed ID: 6365661
[TBL] [Abstract][Full Text] [Related]
19. Hyperglucagonaemia in obese children.
Chiumello G; Chen R
Lancet; 1968 Aug; 2(7563):353. PubMed ID: 4173766
[No Abstract] [Full Text] [Related]
20. Plasma glucagon in simple obesity: effect of exercise.
Gossain VV; Srivastava L; Rovner DR; Turek D
Am J Med Sci; 1983; 286(3):4-10. PubMed ID: 6356919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
